Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/106220
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorChinese Mainland Affairs Officeen_US
dc.contributorDepartment of Health Technology and Informaticsen_US
dc.creatorNicol, AJen_US
dc.creatorChing, JCFen_US
dc.creatorTam, VCWen_US
dc.creatorLiu, KCKen_US
dc.creatorLeung, VWSen_US
dc.creatorCai, Jen_US
dc.creatorLee, SWYen_US
dc.date.accessioned2024-05-03T00:45:51Z-
dc.date.available2024-05-03T00:45:51Z-
dc.identifier.urihttp://hdl.handle.net/10397/106220-
dc.language.isoenen_US
dc.publisherMDPI AGen_US
dc.rights© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).en_US
dc.rightsThe following publication Nicol AJ, Ching JCF, Tam VCW, Liu KCK, Leung VWS, Cai J, Lee SWY. Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review. Cancers. 2023; 15(23):5705 is available at https://dx.doi.org/10.3390/cancers15235705.en_US
dc.subjectOral mucositisen_US
dc.subjectDysphagiaen_US
dc.subjectHead and neck canceren_US
dc.subjectPredictive factorsen_US
dc.subjectAcute toxicityen_US
dc.subjectLate toxicityen_US
dc.titlePredictive factors for chemoradiation-induced oral mucositis and dysphagia in head and neck cancer : a scoping reviewen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume15en_US
dc.identifier.issue23en_US
dc.identifier.doi10.3390/cancers15235705en_US
dcterms.abstractSimple Summary: Head and neck cancer is the seventh-most prevalent cancer worldwide. Despite advances in treatment, many patients suffer from chemoradiation-induced oral mucositis and dysphagia, affecting both treatment outcome and quality of life. Accurate prediction of the severity of toxicities is important for optimizing management and improving patient outcomes. The aim of this scoping review was to provide recommendations for the improvement in predictive models for oral mucositis and dysphagia. This was achieved by comprehensively mapping the landscape of reported predictors and critically evaluating the performance, methodology, and reporting of predictive models for these conditions. Implementation of these improvements is desirable to enable the early detection of patients at high risk of severe toxicity, thereby offering opportunities for preemptive care, intensified support, and, ultimately, improved patient outcomes.----en_US
dcterms.abstractAbstract: Despite advances in head and neck cancer treatment, virtually all patients experience chemoradiation-induced toxicities. Oral mucositis (OM) and dysphagia are among the most prevalent and have a systemic impact on patients, hampering treatment outcome and harming quality of life. Accurate prediction of severe cases is crucial for improving management strategies and, ultimately, patient outcomes. This scoping review comprehensively maps the reported predictors and critically evaluates the performance, methodology, and reporting of predictive models for these conditions. A total of 174 studies were identified from database searches, with 73 reporting OM predictors, 97 reporting dysphagia predictors, and 4 reporting both OM and dysphagia predictors. These predictors included patient demographics, tumor classification, chemoradiotherapy regimen, radiation dose to organs-at-risk, genetic factors, and results of clinical laboratory tests. Notably, many studies only conducted univariate analysis or focused exclusively on certain predictor types. Among the included studies, numerous predictive models were reported: eight for acute OM, five for acute dysphagia, and nine for late dysphagia. The area under the receiver operating characteristic curve (AUC) ranged between 0.65 and 0.81, 0.60 and 0.82, and 0.70 and 0.85 for acute oral mucositis, acute dysphagia, and late dysphagia predictive models, respectively. Several areas for improvement were identified, including the need for external validation with sufficiently large sample sizes, further standardization of predictor and outcome definitions, and more comprehensive reporting to facilitate reproducibility.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationCancers, Dec. 2023, v. 15, no. 23, 5705en_US
dcterms.isPartOfCancersen_US
dcterms.issued2023-12-
dc.identifier.isiWOS:001115974400001-
dc.identifier.eissn2072-6694en_US
dc.identifier.artn5705en_US
dc.description.validate202405 bcrcen_US
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOS-
dc.description.fundingSourceOthersen_US
dc.description.fundingTextShenzhen Basic Research Programen_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
cancers-15-05705.pdf519.14 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

13
Citations as of Jun 30, 2024

Downloads

3
Citations as of Jun 30, 2024

SCOPUSTM   
Citations

2
Citations as of Jun 21, 2024

WEB OF SCIENCETM
Citations

1
Citations as of Jul 4, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.